150 related articles for article (PubMed ID: 6348069)
1. Immunocytochemical localisation of katacalcin, a calcium-lowering hormone cleaved from the human calcitonin precursor.
Ali-Rachedi A; Varndell IM; Facer P; Hillyard CJ; Craig RK; MacIntyre I; Polak JM
J Clin Endocrinol Metab; 1983 Sep; 57(3):680-2. PubMed ID: 6348069
[TBL] [Abstract][Full Text] [Related]
2. Molecular forms of katacalcin, calcitonin gene-related peptide and gastrin-releasing peptide, in a human medullary thyroid carcinoma.
Conlon JM; McGregor GP; Wallin G; Grimelius L; Thim L
Cancer Res; 1988 May; 48(9):2412-6. PubMed ID: 3258543
[TBL] [Abstract][Full Text] [Related]
3. Adrenocorticotropin and calcitonin in medullary thyroid carcinoma: frequency of occurrence and localization in the same cell type by immunocytochemistry.
Goltzman D; Huang SN; Browne C; Solomon S
J Clin Endocrinol Metab; 1979 Sep; 49(3):364-9. PubMed ID: 224074
[No Abstract] [Full Text] [Related]
4. A neuroendocrine peptide derived from the amino-terminal half of rat procalcitonin.
Burns DM; Birnbaum RS; Roos BA
Mol Endocrinol; 1989 Jan; 3(1):140-7. PubMed ID: 2915645
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of calcitonin gene-related peptide in human medullary carcinoma and C cell hyperplasia.
Williams ED; Ponder BJ; Craig RK
Clin Endocrinol (Oxf); 1987 Jul; 27(1):107-14. PubMed ID: 3498562
[TBL] [Abstract][Full Text] [Related]
6. Medullary carcinoma of the thyroid. An immunocytochemical and histochemical study of 25 cases using eight separate markers.
Sikri KL; Varndell IM; Hamid QA; Wilson BS; Kameya T; Ponder BA; Lloyd RV; Bloom SR; Polak JM
Cancer; 1985 Nov; 56(10):2481-91. PubMed ID: 2412687
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of substance P-like immunoreactivity in human thyroid and medullary carcinoma of the thyroid.
Kakudo K; Vacca LL
J Submicrosc Cytol; 1983 Apr; 15(2):563-8. PubMed ID: 6687904
[TBL] [Abstract][Full Text] [Related]
8. Katacalcin: a new plasma calcium-lowering hormone.
Hillyard CJ; Myers C; Abeyasekera G; Stevvensvenson JC; Craig RK; MacIntyre I
Lancet; 1983 Apr; 1(8329):846-8. PubMed ID: 6132180
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical hormone content in medullary and undifferentiated thyroid carcinoma and prognosis after surgery.
Henninger S; Schatz H; Stracke H; Wagner U; Kracht J
Acta Histochem; 1988; 83(1):51-6. PubMed ID: 2897752
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical detection of calcitonin, ACTH, beta-MSH, beta-endorphin and somatostatin in medullary carcinoma of the thyroid. Immunoperoxidase study (PAP, ABC) of 10 cases].
Charpin C; Argemi B; Cannoni M; Oliver C; Gillioz P; Vagneur JP; Toga M
Ann Pathol; 1984; 4(1):27-35. PubMed ID: 6142718
[TBL] [Abstract][Full Text] [Related]
11. Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease.
Mendelsohn G; Wells SA; Baylin SB
Cancer; 1984 Aug; 54(4):657-62. PubMed ID: 6378353
[TBL] [Abstract][Full Text] [Related]
12. Structural characterization of a high-molecular-mass form of calcitonin [procalcitonin-(60-116)-peptide] and its corresponding N-terminal flanking peptide [procalcitonin-(1-57)-peptide] in a human medullary thyroid carcinoma.
Conlon JM; Grimelius L; Thim L
Biochem J; 1988 Nov; 256(1):245-50. PubMed ID: 3265620
[TBL] [Abstract][Full Text] [Related]
13. Identification and localization of 7B2 protein in human, porcine, and rat thyroid gland and in human medullary carcinoma.
Marcinkiewicz M; Benjannet S; Falgueyret JP; Seidah NG; Schürch W; Verdy M; Cantin M; Chrétien M
Endocrinology; 1988 Aug; 123(2):866-73. PubMed ID: 3293987
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin-like immunoreactivity of amyloid fibrils in medullary thyroid carcinomas. An immunoelectron microscope study.
Berger G; Berger N; Guillaud MH; Trouillas J; Vauzelle JL
Virchows Arch A Pathol Anat Histopathol; 1988; 412(6):543-51. PubMed ID: 3129866
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical demonstration of calcitonin cells in the fetal thyroid of mice].
Treilhou-Lahille F; Cressent M; Taboulet J; Moukhtar MS
C R Seances Acad Sci D; 1979 Sep; 289(4):421-3. PubMed ID: 117948
[TBL] [Abstract][Full Text] [Related]
16. [Katacalcin--a new tumor marker in C-cell cancer of the thyroid gland].
Raue F; Boden M; Girgis S; Rix E; Ziegler R
Klin Wochenschr; 1987 Jan; 65(2):82-6. PubMed ID: 3550267
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactive calcitonin in amyloid fibrils of medullary carcinoma of the thyroid gland. An immunogold staining technique.
Butler M; Khan S
Arch Pathol Lab Med; 1986 Jul; 110(7):647-9. PubMed ID: 2424399
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies against calcitonin. Characterization and application in light and electron microscopy immunocytochemistry.
Scopsi L; Arias J; Houen G; Racchetti G; Fossati GL; Galante YM
Histochemistry; 1988; 88(2):113-25. PubMed ID: 3346173
[TBL] [Abstract][Full Text] [Related]
19. Medullary carcinomas of the thyroid contain immunoreactive human chorionic gonadotropin alpha subunit.
Wurzel JM; Kourides IA; Brooks JS
Horm Metab Res; 1984 Dec; 16(12):677. PubMed ID: 6084634
[No Abstract] [Full Text] [Related]
20. Somatostatin-immunoreactive cells in medullary carcinoma of the thyroid.
Sundler F; Alumets J; Håkanson R; Björklund L; Ljungberg O
Am J Pathol; 1977 Aug; 88(2):381-6. PubMed ID: 195473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
